Crossref
Administration route of progesterone in combined HRT as a predictor of breast cancer risk in menopausal women: a review
Primary Health Care · 02.12.2025 · 35 (6) · 36-41
DOI: 10.7748/phc.2025.e1845 ↗Kurz gefasst
Fachartikel in der Zeitschrift Primary Health Care, online erschienen am 22.01.2025. Verfasst von Elizabeth Kate Woodward und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Woodward, E. K., & Halliday, L. (2025). Administration route of progesterone in combined HRT as a predictor of breast cancer risk in menopausal women: a review. Primary Health Care, 35(6), 36-41. https://doi.org/10.7748/phc.2025.e1845
Vancouver
Woodward EK, Halliday L. Administration route of progesterone in combined HRT as a predictor of breast cancer risk in menopausal women: a review. Primary Health Care. 2025;35(6):36-41. doi:10.7748/phc.2025.e1845
BibTeX
@article{Woodward2025,
author = {Woodward, Elizabeth Kate and Halliday, Lesley},
title = {Administration route of progesterone in combined HRT as a predictor of breast cancer risk in menopausal women: a review},
journal = {Primary Health Care},
year = {2025},
volume = {35},
number = {6},
pages = {36--41},
doi = {10.7748/phc.2025.e1845}
}
EUVIMED